Trials / Withdrawn
WithdrawnNCT02536092
A Prospective Multi-Center Study of a Novel Dual-Wavelength Laser for Hair Removal
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Cutera Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the safety and efficacy of the Cutera excel HR dual wavelength 755nm Alexandrite and 1064nm Nd:YAG laser for hair removal.
Detailed description
This is a multi-center prospective, open-label, uncontrolled multi-center study of up to 50 male or female subjects, age 18 to 65 years, who desire laser hair removal. Subjects will receive 6 hair removal treatments, spaced 8 weeks apart, and will be followed at 12 weeks post-final treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | 755nm and 1064nm Nd:YAG laser | Dual wavelength 755nm and 1064nm Nd:YAG laser |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2016-12-01
- Completion
- 2016-12-01
- First posted
- 2015-08-31
- Last updated
- 2023-01-26
Locations
2 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT02536092. Inclusion in this directory is not an endorsement.